BIOFRONTERA AG (BFRA)
ADR
Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costs
Leverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the “Company”) (Nasdaq: BFRA; Frankfurt Stock Exchange: B8F), an international...
Biofrontera AG announces mediation results
Leverkusen, Germany, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (ISIN: DE0006046113) has been in...
Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021
Leverkusen, Germany, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international...
Biofrontera AG announces initiation of clinical studies
Leverkusen, Germany, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international...
Biofrontera AG: Conference call to discuss third quarter 2021 financial results to be held on November 18, 2021
Leverkusen, Germany, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international...
Biofrontera AG receives FDA-approval of the BF-RhodoLED® XL lamp
Leverkusen, Germany, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international...
Biofrontera reports preliminary revenue for the month of August 2021
Biofrontera reports financial results for the six months ended June 30, 2021
Biofrontera AG: Conference call to discuss half-year 2021 financial results to be held on August 20, 2021
Biofrontera reports preliminary revenue for the month of July 2021
Biofrontera enters into license and supply agreement with Medac for the marketing of Ameluz® in Poland
Biofrontera Inc. seeks IPO in the USA
Biofrontera reports preliminary revenue for the month of June 2021
Biofrontera provides update on clinical developments
Biofrontera reports preliminary revenue for the month of May 2021
Leverkusen, Germany, June 07, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an internat...
Biofrontera reports preliminary revenue for the month of May 2021